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A distinct rotavirus strain (PTRV) was isolated in cell cultures from a stool sample obtained from a diarrheic 3-year-old female pig-tailed
macaque (Macaca nemestrina) that was born at the breeding colony of the University of Washington in Seattle. Unlike other known simian
rotavirus strains including vervet monkey rotavirus SA11 which bears P5B[2]:G3 or P6[1]:G3 specificity, rhesus monkey rotavirus MMU18006
with P5B[3]:G3 specificity, pig-tailed macaque rotavirus YK-1 with P[3]:G3 specificity and rhesus monkey rotavirus TUCH with P[24]:G3
specificity, the cell-culture-grown PTRV strain was shown to bear P6[1]:G8 specificity as determined by VP4 (P)- and VP7 (G)-specific
neutralization assays as well as gene sequence analyses. The virus in the original diarrhea stool was also shown to bear genotypes P[1] and G8. In
addition, the PTRV strain exhibited a ‘‘long’’ electropherotype, subgroup I specificity and NSP4 genotype A specificity. The PTRV probe formed
(i) 8–9 hybrid bands with genomic RNAs of various bovine rotavirus strains and (ii) only 2–3 hybrid bands with simian rotavirus RNAs as
demonstrated by RNA–RNA hybridization, suggesting a possible bovine origin of the virus. Serologic analysis of serum samples obtained from
selected pig-tailed macaques in the colony suggested that a rotavirus bearing P[1]:G8 specificity was endemic among macaques for at least 8 years
(1987–1994). This is the first report describing an isolation of a simian rotavirus bearing a non-G3 VP7 and possibly a P6[1] specificities.
Because of its unique simian serotype, this virus may prove to be valuable in challenge studies in a non-human primate model in studies of
rotavirus immunity.
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Group A rotaviruses are the single most important etiologic
agents of severe diarrhea of infants and young children
worldwide and are estimated to be responsible for a median
of approximately 440,000 deaths each year among children <5
years of age, primarily in the developing countries (Kapikian et
al., 2001; Parashar et al., 2003). Thus, the development and0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: thoshino@niaid.nih.gov (Y. Hoshino).implementation of a safe and effective rotavirus vaccine remain
important global public health goals.
Group A rotaviruses are ubiquitous in almost all mammalian
and avian species with some rare exceptions such as guinea
pigs and rats which do not undergo natural group A rotavirus
infection (Kapikian et al., 2001). Since humans and non-human
primates share various similar genetic and physiologic char-
acteristics, rotavirus strains isolated from non-human primates
have received special attention, being used extensively in both
basic and applied rotavirus research. For example, (i) strain
SA11 isolated from a healthy vervet monkey in South Africa in
1958 and cultivated efficiently in cell culture (Malherbe and
Strickland-Cholmley, 1967) has been a prototype strain of006) 1 – 12
www.e
Y. Hoshino et al. / Virology 345 (2006) 1–122group A rotaviruses and played a central role in our
understanding of molecular biology of rotaviruses (Estes,
2001) and (ii) strain MMU18006 isolated from a diarrheic
rhesus monkey in the United States in 1979 (Stuker et al.,
1980) is the serotype 3 component of a quadrivalent (serotype
1, 2, 3 and 4) vaccine (Midthun et al., 1985, 1986), which was
the first licensed human rotavirus vaccine in the US (Rota-
Shield, Wyeth-Lederle Vaccines and Pediatrics, Philadelphia,
PA; Biovirx, USA) (Advisory Committee on Immunization
Practices, 1999; Spiegel, 2003).
A complete rotavirus particle possesses a triple-capsid
architecture: outer, intermediate and inner capsid or core.
The core encases 11 segments of double-stranded (ds) RNA
that encode 6 structural (VP1–4, 6 and 7) and 6 nonstructural
(NSP1–6) proteins. Outer capsid proteins VP4 (spike protein)
and VP7 (major surface glycoprotein) are independent
neutralization (Greenberg et al., 1985; Hoshino et al., 1985;
Offit and Blavat, 1986) and protective (Hoshino et al., 1988;
Matsui et al., 1989; Offit et al., 1986) antigens. Thus,
rotavirus has a binary system for serotype classification and
nomenclature: VP7 or G (VP7 is a glycoprotein) serotype and
VP4 or P (VP4 is protease sensitive) serotype (Estes, 2001;
Kapikian et al., 2001). By definition, ‘‘serotype’’ is a type
determined by serological methods with neutralization assay
as the keystone, whereas ‘‘genotype’’ is a type determined by
non-serological methods such as RT-PCR, hybridization or
gene sequencing. Fourteen G serotypes (15 G genotypes) and
14 P serotypes (25 P genotypes) have been established thus
far (Liprandi et al., 2003; Martella et al., 2003; McNeal et al.,
2005; Rahman et al., 2005). The number of rotavirus G and P
types detected varies markedly from one animal species to
another. For example, eleven G types and 12 P types have
been detected in humans, whereas only one G and 2 P types
have been detected in mice. Among the established 15 G
types, G3 presents unique features: (i) it has the broadest
animal host range which includes human, rhesus monkey,
vervet monkey, pig-tailed macaque, horse, cow, goat, pig,
dog, cat, rabbit and mouse; and (ii) in some animal species
(e.g., mouse, rabbit, cat, dog and simians), the G3 has been
the only type detected.
Although various species of non-human primates have
played an indispensable role in basic research as well as in
vaccine development of many infectious diseases of humans
such as HIV and viral hepatitis, only a few simian rotavirus
strains have been isolated and characterized. Only five simian
rotavirus strains have been reported; (i) the vervet monkey
rotavirus SA11 strain (Malherbe and Strickland-Cholmley,
1967; Estes et al., 1982; Mattion and Estes, 1991); (ii) the
rhesus monkey rotavirus MMU18006 and MMU17959 strains
(Stuker et al., 1980); (iii) pig-tailed macaque rotavirus YK-1
strain (Westerman et al., 2005a); and (iv) rhesus monkey
rotavirus TUCH strain (McNeal et al., 2005). A major reason
why we have so few simian rotavirus strains may be because
of a lack of surveillance, as all simian rotaviruses are thought
to belong to G3, which may have restricted the development
of a homologous simian rotavirus model, which would be
important if a challenge model with a different serotype wereavailable. In this paper, we report the isolation in cell cultures
of a rotavirus strain (PTRV) derived from a diarrheic pig-
tailed macaque and the determination of (i) the G and P
specificities of the isolate by VP4- and VP7-specific
neutralization and nucleotide sequence analyses, (ii) selected
basic characteristics including electropherotype, subgroup
specificity and NSP4 genotype, (iii) genetic characteristics
as determined by whole genome RNA–RNA hybridization
and (iv) prevalence of this virus among pig-tailed macaques in
the colony.
Results and discussion
Isolation and characterization of pig-tailed macaque rotavirus
PTRV strain
A rotavirus strain was isolated from a female pig-tailed
macaque born in 1987 at the Medical Lake breeding facility of
the Washington Regional (now National) Primate Center, the
University of Washington, Seattle, Washington. Approximately
2 months after being put into group housing at 3 years of age,
the monkey developed diarrhea, and a diarrheal stool sample
was collected for examination. According to the animal
records, this specific pig-tailed macaque had had diarrhea
episodes often and various diarrhea-causing bacteria and/or
parasites had been detected. However, on the date the animal
was admitted to the treatment room in 1990, no such bacteria
and/or parasites were detected. A rotavirus (designated as the
PTRV strain) was isolated in MA104 cell cultures from this
stool specimen. The virus isolate was passaged serially twice in
MA104 cells and sent to the National Institutes of Health
(NIH), Bethesda, Maryland for further characterization. At the
NIH, the virus was passaged once in MAl04 cells and then
plaque-purified three times. The plaque-purified PTRV virus
was used for analysis of various phenotypic and genotypic
characteristics of the virus as well as for immunization of
guinea pigs. The plaque-purified PTRV stain exhibited a
‘‘long’’ electropherotype as determined by polyacrylamide gel
electrophoresis (PAGE), which was distinct from that of
selected human and animal rotavirus strains including those
of simian (strains SA11 [G3] and MMU18006 [G3]), human
(strains 69M [G8], 1290 [G8] and HAL1166 [G8]) and bovine
(strains Cody [G8], 678 [G8], NCDV [G6] and UK [G6])
origin (Fig. 1), indicating that the PTRV virus was not a
laboratory contaminant introduced at the NIH. The electro-
pherotype of viruses present in the first passage MAl04 cell
lysate was identical to that of the plaque-purified PTRV strain
(Fig. 2), indicating that the PTRV virus was not a laboratory
contaminant introduced at the University of Washington. In
addition, when the virus was isolated in cell cultures from a
diarrheal stool sample, no bovine rotaviruses existed in the
laboratory. Analysis of RNA extracted from the approximately
20% original diarrheal stool suspension that was kept at70 -C
failed to produce a visible pattern in a silver-stained PAGE gel,
indicating that the virus was not shed in large number in the
stool. The PTRV strain was shown to bear subgroup I
specificity (data not shown).
Fig. 2. Electrophoretic migration patterns of genomic RNAs of triply plaque-
purified PTRV strain (lane 1) and the virus isolated in MA104 cell cultures
from stool sample obtained from pig-tailed macaque with diarrhea (the first cell
culture passage material) (lane 2).
Fig. 1. Electrophoretic migration patterns of genomic RNAs of selected simian,
human and bovine rotavirus strains (listed at the top) in 10% polyacrylamide
gel. Genomic RNAs were electophoresed at 13 mA for 15 h, and the resulting
migration patterns were visualized by staining of gel with silver nitrate.
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of the PTRV strain
Tables 1, 2 and 3 summarize the neutralization character-
istics of outer capsid proteins VP7 and VP4 of the PTRV strain.
First, the PTRV virus was tested against a battery of antisera
raised to selected reference rotavirus strains belonging to G1–
G14. As shown in Table 1, the PTRV strain was: (i) neutralized
to a high titer (1:10,240–1:20,480) which was well within 20
antibody units of the homologous titer by guinea pig
hyperimmune antiserum raised to each of 3 G8 strains with
differing VP4 specificities (69M, Cody and 678); (ii) neutral-
ized by antiserum to NCDV (P6[1]:G6) to a moderate titer
(1:640) which was 16-fold lower than the homologous titer
(1:10,240); and (iii) neutralized to a low titer (1:80–1:160) by
antiserum to P, SA11 or L338, which was more than 20
antibody units beyond its homologous titer. These results
suggested from this one-way test that the PTRV strain belonged
to serotype G8 and P6.
Next, we performed reciprocal neutralization assays in
which two different antisera raised to the PTRV were tested
against various reference rotavirus strains representing G1–
G14 (Table 2) to determine if there was a two-way ‘‘G8, P6’’
relationship. Antisera to PTRV (i) neutralized each of five G8
rotavirus strains (69M, 1290, HAL1166, Cody and 678) to a
titer similar or identical to that of the PTRV strain (1:10,240–1:20,480), (ii) neutralized the G6 NCDV strain to a 4- to 8-fold
lower titer which was within 20 antibody units of its
homologous titer and (iii) neutralized the G3, G5, G11, G13
and G14 viruses to a low titer of 1:160–1:320 which was not
within 20 antibody units of its homologous titer. These results
indicated that in this one-way test the PTRV strain shared (i)
high levels of neutralization specificity with G8 viruses which
was most likely via VP7 because of the different VP4
specificities of the G8 strains and (ii) high levels of
neutralization specificity with the NCDV strain which may
have been via VP4.
In order to clarify the VP4 serotype specificity of the PTRV
virus, we generated several reassortant rotaviruses and their
antisera in an attempt to dissociate the VP7–VP4 specificities.
As shown in Table 3, the PTRV virus was neutralized to a high
titer by antiserum to reassortant DS-1  69M which bore a
single VP7 gene of human rotavirus 69M with G8 specificity
and the remaining 10 genes of human rotavirus DS-1 strain.
Moreover, in a reciprocal reassortant with regard to VP4 and
VP7, the virus was not neutralized significantly by antiserum to
reassortant 69M  DS-1 (P4[10]:G2) which bore only the 69M
VP4 and the remaining genes from DS-1. In addition, the
PTRV was not neutralized by antiserum to reassortant
HAL1166  DS-1 (P11[14]:G2) which bore only the
HAL1166 VP4 and the remaining genes from DS-1, indicating
again that the PTRV VP7 bore G8 specificity because of the
high degree of neutralization of the HAL1166 strain by
antiserum to the PTRV as shown previously in Table 2.
Furthermore, antiserum to PTRV  DS-1 (P?:G2) neutralized
the PTRV strain to a titer similar or identical to that of
antiserum raised to G2 reassortant NCDV  DS-1 (P6[1]:G2)
or Cody  DS-1 (P6[1]:G2), indicating that the PTRV, NCDV
and Cody strains shared the same P6 specificity. The PTRV
Table 1
Neutralization profile of guinea pig hyperimmune antiserum raised to selected prototype rotavirus strains belonging to G1–G14 against pig-tailed macaque rotavirus
PTRV strain
Rotavirus Antibody titera of guinea pig hyperimmune antiserum raised to indicated rotavirus strain
Strain G type P type Wa DS-1 P SA11 ST3 OSU UK NCDV Ch2
(P1A[8]:G1) (P1B[4]:G2) (P1A[8]:G3) (P5B[2]:G3) (P2A[6]:G4) (P9[7]:G5) (P7[5]:G6) (P6[1]:G6) (P?:G7)
PTRV ? ? <80 <80 80 160 <80 <80 <80 640 <80
69M Cody 678 WI61 B223 YM L26 L338 FI23
(P4[10]:G8) (P6[1]:G8) (P7[5]:G8) (P1A[8]:G9) (P8[11]:G10) (P9[7]:G11) (P1B[4]:G12) (P[18]:G13) (P4[12]:G14)
PTRV ? ? 20480 10240 10240 <80 <80 <80 <80 80 <80
a Reciprocal of 60% plaque reduction neutralization antibody titer. The homologous 60% PRN antibody titers ranged from 10,240 to >81,920 in previous test, in
this laboratory.
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not within 20 antibody units of its homologous titer by
antiserum raised to each of three G3 reassortants DS-1  P
(P1B[4]:G3), DS-1  RRV (P1B[4]:G3) and DS-1  SA11
(P1B[4]:G3) with identical VP4 specificity, indicating that low
levels of cross-reactivity between the G8 PTRV virus and G3
viruses (Table 1) were due to shared low levels of VP7
antigenic specificity because, as shown in Table 1, antisera to a
P1B virus failed to neutralized the PTRV. Low levels (i.e., less
than 20 antibody units) of neutralization cross-reactivity
between G8 and G3 viruses were not unexpected since theyTable 2
Neutralization profile of guinea pig hyperimmune antisera raised to pig-tailed macaq
to G1–G14
Rotaviruses against which guinea pig PTRV antisera were tested
Strain Host Country
of origin
Year
collected
G
type
P type
[genotype]
Wa Human USA 1974 1 1A[8]
DS-1 Human USA 1976 2 1B[4]
P Human USA 1974 3 1A[8]
AU-1 Human Japan 1982 3 3[9]
Ro1845 Human Israel 1985 3 5A[3]
MMU18006 Simian USA 1979 3 5B[3]
SA11 Simian S. Africa 1958 3 5B[2]
ST3 Human UK 1975 4 2A[6]
OSU Porcine USA 1976 5 9[7]
UK Bovine UK 1973 6 7[5]
NCDV Bovine USA 1967 6 6[1]
Ch2 Chicken UK 1980b 7 ?
69M Human Indonesia 1979–81 8 4[10]
1290 Human Kenya 1991–94 8 1B[4]
HAL1166 Human Finland 1986 8 11[14]
Cody Bovine USA 1995b 8 6[1]
678 Bovine UK 1984b 8 7[5]
WI61 Human USA 1983 9 1A[8]
B223 Bovine USA 1983b 10 8[11]
YM Porcine Mexico 1983 11 9[7]
L26 Human Philippines 1987–88 12 1B[4]
L338 Equine UK 1991b 13 [18]
FI23 Equine UK 1991b 14 4[12]
PTRV Simian USA 1990 ? ?
a Reciprocal of 60% plaque reduction neutralization antibody titer. The homolog
b Year published.
c Homologous values are underlined.share high level of amino acid identity in antigenic region C
(VR8) of the VP7 protein (Green et al., 1989). In addition, a
VP7-specific monoclonal antibody that neutralizes both G3 and
G8 viruses has been generated (Kobayashi et al., 1991).
Although antiserum to SA11  DS-1 (P5B[2]:G2) did not
neutralize the PTRV virus, antiserum to RRV  DS-1
(P5B[3]:G2) neutralized the virus to a low titer (1:320)
(Table 3) which was not within 20 antibody units of its
homologous titer, indicating that the PTRV and RRV shared
low levels of neutralization cross-reactivity not only on VP7
but also on VP4. Low levels of VP4 neutralization cross-ue rotavirus PTRV strain against selected prototype rotavirus strains belonging
Antibody titera of guinea pig hyperimmune
antiserum to PTRV versus indicated virus
Reference
serum #1 serum #2
<80 <80 Wyatt et al., 1982
<80 <80 Wyatt et al., 1982
160 160 Wyatt et al., 1982
160 160 Kitaoka et al., 1987
320 160 Aboudy et al., 1988
320 320 Stuker et al., 1980
320 160 Malherbe and
Strickland-Cholmley, 1967
<80 <80 Wyatt et al., 1983
320 320 Bohl et al., 1984
<80 <80 Woode et al., 1975
2560 2560 Mebus et al., 1971
<80 <80 McNulty et al., 1980
20,480 20,480 Matsuno et al., 1985
20,480 10,240 Nakata et al., 1999
10,240 10,240 Gerna et al., 1990
10,240 10,240 Lu et al., 1995
20,480 10,240 Ojeh et al., 1984
<80 <80 Clark et al., 1987
<80 <80 Woode et al., 1983
320 160 Ruiz et al., 1989
<80 <80 Urasawa et al., 1990
160 160 Browning et al., 1991a
320 160 Browning et al., 1991b
20,480c 10,240 This study
ous 60% PRN antibody titers ranged from 10,240 to > 81,920.
Table 3
Neutralization profile of guinea pig hyperimmune antiserum raise to selected reassortant rotaviruses against pig-tailed macaque rotavirus PTRV strain
Rotavirus Antibody titera of guinea pig hyperimmune antiserum raised to indicated reassortant
Strain G type P type DS-1  69M 69M  DS-1 HAL1166  DS-1 NCDV  DS-1 Cody  DS-1 PTRV  DS-1 DS-1  P
(P1B[4]:G8) (P4[10]:G2) (P11[14]:G2) (P6[1]:G2) (P6[1]:G2) (P?:G2) (P1B[4]:G3)
PTRV ? ? 40,960 80 <80 10,240 5120 5120 160
DS-1  RRV DS-1  SA11 SA11  DS-1 RRV  DS-1 OSU  DS-1 YM  DS-1 L338  DS-1
(P1B[4]:G3) (P1B[4]:G3) (P5B[2]:G2) (P5B[3]:G2) (P9[7]:G2) (P9[7]:G2) (P[18]:G2)
PTRV ? ? 640 160 <80 320 160 320 160
a Reciprocal of 60% plaque reduction neutralization antibody titer. The homologous 60% PRN antibody titers ranged from 10,240 to 40,960 in previous tests in
this laboratory.
Y. Hoshino et al. / Virology 345 (2006) 1–12 5reactivity between viruses bearing P5B[3] (RRV) and P6[1]
(NCDV) specificities were reported previously (Midthun et
al., 1985).
Antiserum to each of three G2 reassortants OSU  DS-1
(P9[7]:G2), YM  DS-1 (P9[7]:G2) or L338  DS-1
(P[18]:G2) neutralized the PTRV virus to a low titer (1:160–
1:320), which was not within 20 antibody units of its
homologous titer, indicating that the cross-reactivity observed
between the PTRVand OSU, YM or L338 (Table 1) was due to
shared low levels of VP4 cross-reactivity. Thus, these
neutralization results demonstrated that the PTRV strain bore
a P6:G8 specificity.
The virus in the original stool obtained from diarrheal pig-
tailed macaque was shown by PCR typing assay to bear
genotypes P[1] and G8, confirming that the PTRV strain was
not a laboratory contaminant.
Sequence analysis of the gene encoding VP7, VP8* or NSP4 of
the PTRV strain
The deduced amino acid (aa) sequence identity of the PRTV
VP7 for selected G8 strains ranged from 93.9% (humanFig. 3. Phylogenetic analysis of VP7 genes of the PTRV strain and other rotavirus str
to G8 type. Phylogenetic tree was constructed by employing the Clustal W algorithm
length of each pair of branches represents the distance between sequence pairs.rotavirus MW23 strain) to 98.6% (bovine rotavirus Tokushima
9503 strain and guanaco rotavirus GRV Rio Negro strain).
Consistent with this finding, phylogenetic analysis of the VP7
gene indicated that the PTRV VP7 gene was more closely
related to that of Tokushima9503 or GRV Rio Negro than that
of MW23 (Fig. 3).
The PTRV VP8* gene demonstrated the highest nucleotide
(nt) identity with that of P[1] viruses (e.g., 97.0% with bovine
rotavirus NCDV strain, 96.9% with bovine rotavirus C486
strain and 95.0% with simian rotavirus SA114fM strain),
suggesting that the PTRV VP4 gene belonged to P[1]
genotype. This finding was in agreement with neutralization
characteristics of the PTRV VP4 (Tables 1, 2 and 3).
Phylogenetic analysis of the PTRV VP8* gene demonstrated
that it clustered with that of other P[1] viruses (Fig. 4).
Analysis of NSP4 gene of the PTRV showed that it
belonged to NSP4 genotype A: 96.7% nt identity versus
genotype A bovine rotavirus RF strain, 83.7% nt identity
versus genotype B human rotavirus Wa strain and 82.7% nt
identity versus genotype C human rotavirus AU-1 strain. This
finding was confirmed by phylogenetic analysis of selected
NSP4 genes belonging to genotype A, B or C which indicatedains representative of the 15 G types indicates that the PTRV VP7 gene belongs
of the MegAlign program in DNASTAR software package (Madison, WI). The
Fig. 5. Phylogenetic analysis of NSP4 genes of the PTRV and other rotavirus strains representative of 3 genotypes indicates that the PTRV NSP4 gene belongs to
NSP4 genotype A. Phylogenetic tree was constructed by employing the Clustal W algorithm of the MegAlign program in DNASTAR software package (Madison,
WI). The length of each pair of branches represents the distance between sequence pairs.
Fig. 4. Phylogenetic analysis of VP8* genes of the PTRVand other rotavirus strains representative of 25 P genotypes indicates that the PTRV VP8* gene belongs to
P[1] type. Phylogenetic tree was constructed by employing the Clustal W algorithm of the MegAlign program in DNASTAR software package (Madison, WI). The
length of each pair of branches represents the distance between sequence pairs.
Y. Hoshino et al. / Virology 345 (2006) 1–126
Fig. 6. Hybridization patterns between a 32P-labeled PTRV RNA probe and RNAs of selected bovine, simian, porcine and human rotavirus strains (listed at the top).
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rotaviruses (Fig. 5).
Genetic analysis of the PTRV whole genome as determined by
RNA–RNA hybridization in solution
The PTRV probe formed at least 9 hybrid bands with the
genomic RNAs of US G6 bovine rotavirus NCDV strain and
Japanese G8 bovine rotavirus BRV16 strain, 8 bands with those
of Scottish G8 bovine rotavirus 678 strain and Japanese G10
bovine rotavirus KK3 strain (Fig. 6). Three to four hybrid
bands were formed between the PTRV probe and the genomic
RNAs of simian rotavirus RRV (MMU18006) or SA11,
whereas one to four hybrid bands were formed between the
PTRV probe and the genomic RNAs of human rotavirus Wa,
DS-1 or AU-1 strain or porcine rotavirus OSU strain. These
results indicated that the PTRV strain belonged to the bovine
rotavirus genogroup rather than the simian rotavirus gen-
ogroup. Since, in general, a rotavirus genogroup native to one
animal species is not detected in another animal species (FloresTable 4
Analysis by neutralization of serum samples collected from selected pig-tailed mac
Rotavirus used for neutralization 60% PRN antibo
Strain/reassortant G type P type Macaque #1
(7/16/87)
PTRV 8 P[1] 320
RRV  1290 8 P[3] 80
PTRV  DS-1 2 P[1] 80
MMU18006 (RRV) 3 P[3] <40
DS-1 2 P[4] <40et al., 1986; Nakagomi and Nakagomi, 1993, 2002), this
finding appears to suggest that the PTRV may be of bovine
origin.
Rotaviruses bearing a P[1]:G8 specificity appeared to have
been endemic in the monkey colony
As summarized in Table 4, all five serum samples derived
from three pig-tailed macaques that were collected at Medical
Lake colony between 1987 and 1994 had neutralizing
antibodies to P[1]:G8 virus PTRV, suggesting that all 3
macaques in the colony were infected with a virus bearing a
P[1] and/or G8 specificity. The finding that four of five serum
samples had (i) antibodies to a reassortant RRV  1290
(P[3]:G8) and (ii) no antibodies to RRV (P[3]:G3) indicated
that the virus bore G8 specificity. Of note is the finding that
two samples collected before 1990 as well as three samples
collected after 1990 (when one macaque developed diarrhea
from which the PTRV virus was isolated) had also neutralizing
antibodies to the PTRV virus, suggesting a G8 virus such asaques in the colony
dy titer of indicated serum (date blood collected)
Macaque #2 Macaque #3
(10/29/91) (1/21/88) (8/19/94) (1/12/94)
320 1280 2560 640
80 640 640 320
160 1280 2560 320
<40 <40 80 <40
<40 <40 40 <40
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colony during at least 1987 and 1994. It is interesting to
note that (i) four of five serum samples did not have
neutralizing antibodies (<1:40) to G3 virus RRV and (ii)
only one sample had low level of antibodies (1:80) to the
RRV virus which was probably induced by the G8 virus
infection(s) due to the shared high level of amino acid
identity in VP7 antigenic region C (amino acid residues
208–224) between the G3 and G8 viruses. This observation
suggested that the Medical Lake monkey colony was free
from G3 virus (the only G type detected thus far from non-
human primates) for at least 8 years (from 1987 to 1994).
Four of five serum samples had (i) antibodies to a
reassortant PTRV  DS-1 (P[1]:G2) and (ii) no antibodies
to DS-1 (P[4]:G2), indicating that the virus endemic in the
colony bore a P[1] specificity. Thus, these data demonstrated
that the virus that infected three monkeys tested bore a
P[1]:G8 specificity like the PTRV strain. If the SA11 viruses
bearing P[1] specificity (Pereira et al., 1984, 1986; Burns et
al., 1989; Lo´pes and Arias, 1992) were derived from the
original stool sample obtained from a healthy vervet monkey
(Malherbe and Strickland-Chomley, 1967), then it would
suggest that a virus bearing P[1] specificity can replicate in
monkey small intestine. This assumption may render support
to our finding that a PTRV-like virus bearing P[1] specificity
was endemic among pig-tailed macaques for at least 8 years
in the colony.
At the Medical Lake breeding facility, the macaques
were kept indoors in breeding family groups of approxi-
mately 20. However, there was many transfer between
groups with the possibility of moving pathogens throughout
the facility.
A rotavirus strain bearing a G8 specificity
G8 rotaviruses were first detected in Indonesia from
children with diarrhea during 1978–81 (Matsuno et al.,
1985; Albert et al., 1987). Prototype strains (69M and B37)
of such Indonesian G8 viruses with a characteristic ‘‘super
short’’ electropherotype (Fig. 1) were reported later to bear a
P4[10] specificity. Since then, the G8 viruses have been
isolated sporadically from patients with diarrhea in various
parts of the world in association with various P types
including P[4], P[6] and P[14] (Adah et al., 1997; Bishop et
al., 2001; Cooney et al., 2001; Gerna et al., 1990; Holmes et
al., 1999; Jagannath et al., 2000; Kang et al., 2002; Kelkar
and Ayachit, 2000; Palombo et al., 2000). Recently,
however, the G8 viruses in conjunction with P[4] or P[6]
specificity have been detected in diarrheal patients at higher
frequency especially in certain countries in Africa (Adah et
al., 2001; Armah et al., 2001; Cunliffe et al., 2000, 2001,
2002; Fischer et al., 2003; Nakata et al., 1999; Santos and
Hoshino, 2005; Steele et al., 2002). For example, (i) in
Blantyre, Malawi, during the 1997–1999 season, the G8
viruses were the most prevalent G type (34.8%) followed by
G1 (30%) and (ii), in Maiduguri, Nigeria, during the 1999–
2000 season, the G8 was the second most prevalent (27.7%)after G1 (39.3%). Thus, a rhesus- or bovine (UK)-based
single VP7 (G8) gene substitution reassortant vaccine
candidate has been constructed (Hoshino et al., 2003). Such
a G8 vaccine component could be added to the existing
tetravalent vaccine to formulate a pentavalent (G1, G2, G3,
G4 and G8) or hexavalent (G1, G2, G3, G4, G8 and G9)
vaccine (Kapikian et al., 2005).
The G8 serotype is perhaps the third most common G
type found in cattle after G6 and G10 (Chang et al., 1996;
Falcone et al., 1999; Fukai et al., 1999, 2002; Okada and
Matsumoto, 2002; Parwani et al., 1993; Snodgrass et al.,
1990; Suzuki et al., 1993). The bovine G8 viruses have been
detected in conjunction with P[1], P[5], P[11] or P[14]
(Adah et al., 2003; Fukai et al., 1999, 2004; Lu et al., 1995;
Sato et al., 1997; Snodgrass et al., 1990; Taniguchi et al.,
1991). In 1996, 1 of 121 rotavirus-positive field samples
collected from foals with or without diarrhea was reported to
bear a P[1]:G8 specificity (Isa et al., 1996). Recently, the
P[1]:G8 viruses have been detected, albeit limited in number,
in humans in parts of India (Jagannath et al., 2000) and
Nigeria (Adah et al., 2001). Since a close association of
people with cattle in such regions is reported to be common,
these bovine-like P[1]:G8 human rotavirus strains are
suspected to be examples of the direct transmission of such
viruses from cattle to humans. More recently, the P[1]:G8
virus was detected in newborn guanacos (Lama guanicoe)
with acute diarrhea in Argentina (Parren˜o et al., 2004). In
the present study, we reported the isolation of a P6[1]:G8
virus (designated as PTRV strain) from a pig-tailed macaque
with diarrhea. The PTRV strain is the first simian rotavirus
shown to carry a non-G3 specificity in conjunction with a
P6[1] specificity. RNA–RNA hybridization assay suggests
that the simian PTRV strain may be of bovine origin.
However, this P[1]:G8 virus, as shown in the present
serology study, was endemic among pig-tailed macaques in
the colony.
Recently, there is renewed interest in establishing a non-
human primate model (Chege et al., 2005; McNeal et al.,
2005; Westerman et al., 2005a, 2005b) (i) to better
understand the mechanisms involved in protective rotavirus
immunity and (ii) to evaluate safety and efficacy of
rotavirus vaccine candidates prior to clinical trials in
humans. One of the obstacles in establishing such a
homologous simian model is that there is only one G type
(G3) existing in simian rotaviruses. Recently, Chege et al.
reported that five of five infant vervet monkeys and one of
two infant baboons that were given by gastric intubation 2
ml of 10–20% stool suspension containing a P[6]:G8 virus
obtained from a child with diarrhea did not develop any
clinical signs but shed virus for 2–8 days and seroconverted
(Chege et al., 2005). These findings suggest that a virus
bearing G8 specificity can replicate in monkey small
intestine and thus can be used in challenge studies. The
PTRV strain with P6[1]:G8 specificity, which was demon-
strated in this study to be able to infect pig-tailed macaques
endemically, may prove to be a valuable virus in challenge
studies in a monkey model.
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Rotavirus strains, cell cultures, culture medium, virus
neutralization assay, subgroup determination, hyperimmune
antiserum and polyacrylamide gel electrophoresis
Table 2 summarizes the reference rotavirus strains used in
this study. Primary or secondary cultures of African green
monkey kidney (AGMK) cells (Diagnostic Hybrids, Athens,
OH) were used for genetic reassortment. An established
monkey kidney MA104 cell line was used for virus amplifi-
cation, plaque purification, virus titration and plaque reduction
neutralization (PRN) assay. Eagle’s minimum essential medium
supplemented with 0.5 Ag/ml trypsin (Sigma g-irradiated
trypsin, Sigma Chemical, St. Louis, MO) and antibiotics was
used as maintenance medium, and Leibovitz l-15 medium
(Quality Biological. Gaithersburg, MD) supplemented with
antibiotics was employed when preparing virus or serum
dilutions. PRN assay was performed in a six-well plate (Costar,
Corning Inc., Corning, NY) using 50–60 plaque-forming units
per 250 Al of the virus as described previously (Hoshino et al.,
1998). Agarose (SeaKem ME, BMA, Rockland, ME) was used
as a solidifying reagent in overlay medium. Hyperimmune
antiserum to each rotavirus strain or reassortant was raised in
specific pathogen-free guinea pigs (Charles River, Wilmington,
MA) which were free of rotavirus neutralizing antibodies (titer
< 1:20 versus PTRV) as determined by PRN assay. At least two
guinea pigs were used for antiserum production against each
virus or reassortant in an attempt to obtain a more accurate
neutralization profile. Sera were inactivated before use by
heating at 56 -C for 30 min. Rotavirus immunogens were
prepared as previously described (Hoshino et al., 2005; Wyatt
et al., 1982). Rotavirus genomic double-stranded (ds) RNAs
were extracted with a mixture of phenol:chloroform:isoamyl
alcohol (25:24:1 v/v, GIBCO Invitrogen Corp, Carlsbad, CA),
precipitated with ethanol and analyzed in a 10% polyacryl-
amide gel as reported previously (Jones et al., 2003). Subgroup
specificity was determined by subgroup-specific monoclonal
antibody-based enzyme-linked immunosorbent assay (ELISA)
as described previously (Greenberg et al., 1983).
Construction, identification and characterization of single VP7
gene substitution PTRV  DS-1 reassortant
Roller tube cultures of primary AGMK cells were coin-
fected at a multiplicity of infection of approximately one with
the human rotavirus DS-1 strain and the pig-tailed macaque
rotavirus PTRV strain. When approximately 75% of the
infected cells exhibited cytopathic effects, the cultures were
frozen and thawed once, and the lysate was plated onto MA104
cells in a six-well plate in the presence of hyperimmune
antiserum to the 69M strain (P4[10]:G8) for selection of the
desired PTRV  DS-1 (P6[1]:G2) reassortant. The desired
single VP7 gene substitution reassortant was selected and
identified and then plaque-purified three times. The origin of
genes of the reassortant was identified by polyacrylamide gel
electrophoresis (PAGE) of its genomic dsRNAs. The origin ofcertain genes which was not able to be determined with
certainty by PAGE was studied further by constant denaturant
gel electrophoresis as previously described (Jones et al., 2003).
Hyperimmune antiserum to each reference rotavirus strain or
reassortant was analyzed for VP4- or VP7-specific antibodies
to selected human and animal rotavirus strains or reassortants
by 60% PRN assay.
Sequence and phylogenetic analyses of the gene encoding VP7,
VP8* or NSP4 of the PTRV strain
Full-length cDNA of the VP7 or NSP4 gene or 876
basepairs (bp) of the VP4 gene of the PTRV strain were
amplified using primer pair Beg9 and End9 (Gouvea et al.,
1990) (for VP7 gene), Wa10F and Wa10R (for NSP4 gene) or
con2 and con3 (Gentsch et al., 1992) (for 876-bp fragment of
VP4) as previously described (Hoshino et al., 2005). The PCR
products were gel-purified using a microcentrifuge method
with a Wizard SV Gel and PCR Clean-up System protocol
(Promega, Madison WI). The nucleotide sequence of the entire
open reading frame of the VP7 gene and NSP4 gene as well as
the VP8* gene were sequenced at least twice using the BigDye
terminator cycle sequencing kit (Applied Biosystems) with
ABI PRISM 310 automated DNA sequencer. Phylogenetic tree
of VP7, VP8* or NSP4 gene of the PTRV strain and other
selected rotavirus strains was constructed by employing the
Clustal W algorithm of the MegAlign program in DNASTAR
software package (Madison, WI). The nucleotide sequences of
the PTRV genes are retrievable from GenBank under the
accession numbers AB180973 (VP7), AB180975 (VP8*) and
AB180979 (NSP4).
RT-PCR genotyping
The genomic dsRNA extracted from approximately 20%
original diarrhea stool suspension was analyzed by RT-PCR
assay for determination of G and P genotypes using primers
reported previously (Isegawa et al., 1993; Gouvea et al., 1994).
RNA–RNA hybridization in solution
Analysis of the genetic composition of the PTRV whole
genome by RNA–RNA hybridization in solution was carried
out as described previously (Flores et al., 1982; Nakagomi et
al., 1989). Briefly, the 32P-labeled single-stranded probe of the
PTRV virus was hybridized to the denatured genomic RNAs of
selected simian, bovine, porcine and human rotaviruses for 16
h at 65 -C, and the resulting hybrids were separated by PAGE.
Autoradiography of each hybrid pattern was compared with the
homologous pattern for analysis of relative reactions of the
whole genome (Nakagomi and Nakagomi, 1993).
Analysis by neutralization of serum samples of selected
pig-tailed macaques in the colony
The pig-tailed macaque from which the PTRV strain was
isolated developed diarrhea in October 1990. Unfortunately,
Y. Hoshino et al. / Virology 345 (2006) 1–1210serum samples derived from this specific macaque were no
longer available for analysis. However, serum samples
collected from other pig-tailed macaques in the same colony
were available, and thus we analyzed a total of five serum
sampled derived from three macaques (#1, #2 and #3) by
neutralization. A pair of samples collected before and after
1990 from macaques #1 and #2 as well as a single sample
collected in 1994 from macaque #3 were included (Table 4).
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